Skip to search formSkip to main contentSkip to account menu

Activated B-Cell-Like Diffuse Large B-Cell Lymphoma

Known as: ABC DLBCL, ABC-DLBCL, Diffuse Large B-Cell Lymphoma with an Activated B-Cell Expression Profile 
A biologic subset of diffuse large B-cell lymphomas with a unique molecular signature or expression profile. It represents approximately 30% of… 
National Institutes of Health

Related topics

Related topics

18 relations
Atypical lymphocyteB lymphoblastB-LymphocytesBCL6 gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Diffuse large B-cell lymphoma in Southeast Asian cohort: expression patterns of B-cell receptor (BCR) repertoire and its linkage with molecular subtypes and response to R-CHOP therapy
Aims Heightened B-cell receptor (BCR) activity in diffuse large B-cell lymphoma (DLBCL) is well established, and a subset of… 
Review
2018
Review
2018
Successful experience of treatment of a patient with generalized non-GCB- DLBCL using the R-mNHL-BFM-90 protocol with lenalidomide: case report and review of literature.
Diffuse large B-cell lymphoma is categorized by gene expression profiling into germinal center (GCB) and activated B-cell (ABC… 
2016
2016
MYC and BCL2 overexpression is associated with a higher class of Memorial Sloan-Kettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the…
Primary diffuse large B-cell lymphoma of the central nervous system (PCNS-DLBCL) is a distinct clinicopathological entity with a… 
2015
2015
A20 Mutation Is Not a Prognostic Marker for Activated B-Cell-Like Diffuse Large B-Cell Lymphoma
Background Constitutive activation of nuclear factor κB (NF-κB) is a hallmark of activated B-cell-like diffuse large B-cell… 
2014
2014
Downregulated expression of Dicer1 predicts inferior survival in primary gastrointestinal diffuse large B-cell lymphoma treated with CHOP-like regimen and rituximab
The aim of this study was to detect the expression levels of Dicer1, Drosha, DGCR8, and Ago2 messenger ribonucleic acids (mRNAs… 
2013
2013
Rituximab in the treatment of diffuse large B-cell lymphoma primary of the lung
Abstract Diffuse large B-cell lymphoma primary of lung (DLBCL-PL) is a rare presentation of extranodal lymphoma, in most cases… 
2013
2013
Transcription factor STAT3 as a prognostic marker and therapeutic target in cancer.
In the early 1990s, researchers identified a mechanism by which cytokines interacting with cell surface receptors could modulate… 
Review
2013
Review
2013
II. Therapy of DLBCL based on genomics
The activated B-cell-like (ABC) and germinal centre B-cell-like (GCB) subtypes of diffuse large B-cell lymphoma (DLBCL) were… 
2009
2009
MicroRNA‐155 expression and outcome in diffuse large B‐cell lymphoma
In a recent report, Roehle et al (2008) described the global microRNA (miRNA) expression signature of B-cell lymphomas. In that… 
2006
2006
Gene Expression Profiling of Diffuse Large B-Cell Lymphomas Supervised by CD21 Expression.
Abstract 4164 Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma and is composed of heterogeneous… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)